These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 24880146)

  • 1. Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities.
    Cavalera M; Wang J; Frangogiannis NG
    Transl Res; 2014 Oct; 164(4):323-35. PubMed ID: 24880146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.
    Russo I; Frangogiannis NG
    J Mol Cell Cardiol; 2016 Jan; 90():84-93. PubMed ID: 26705059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
    Frangogiannis NG
    Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities.
    Tuleta I; Frangogiannis NG
    Adv Drug Deliv Rev; 2021 Sep; 176():113904. PubMed ID: 34331987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of cardiac fibrosis.
    Kong P; Christia P; Frangogiannis NG
    Cell Mol Life Sci; 2014 Feb; 71(4):549-74. PubMed ID: 23649149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.
    Frangogiannis NG
    Circ Res; 2019 Jun; 125(1):117-146. PubMed ID: 31219741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of leptin in obesity-associated cardiac fibrosis: evidence and mechanism.
    Mao Y; Zhao K; Li P; Sheng Y
    Mol Cell Biochem; 2023 May; 478(5):991-1011. PubMed ID: 36214893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblasts and the extracellular matrix in right ventricular disease.
    Frangogiannis NG
    Cardiovasc Res; 2017 Oct; 113(12):1453-1464. PubMed ID: 28957531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts.
    Leifheit-Nestler M; Kirchhoff F; Nespor J; Richter B; Soetje B; Klintschar M; Heineke J; Haffner D
    Nephrol Dial Transplant; 2018 Oct; 33(10):1722-1734. PubMed ID: 29425341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Cardiac Lymphatics in Myocardial Edema and Fibrosis: JACC Review Topic of the Week.
    Brakenhielm E; González A; Díez J
    J Am Coll Cardiol; 2020 Aug; 76(6):735-744. PubMed ID: 32762908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.
    Prabhu SD; Frangogiannis NG
    Circ Res; 2016 Jun; 119(1):91-112. PubMed ID: 27340270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.
    Gonzalez-Quesada C; Cavalera M; Biernacka A; Kong P; Lee DW; Saxena A; Frunza O; Dobaczewski M; Shinde A; Frangogiannis NG
    Circ Res; 2013 Dec; 113(12):1331-44. PubMed ID: 24081879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Leptin in Cardiovascular Diseases.
    Poetsch MS; Strano A; Guan K
    Front Endocrinol (Lausanne); 2020; 11():354. PubMed ID: 32655492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic fibrosis.
    Tuleta I; Frangogiannis NG
    Biochim Biophys Acta Mol Basis Dis; 2021 Apr; 1867(4):166044. PubMed ID: 33378699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of nuclear factor erythroid 2-related factor 2 signaling and activation of fibrogenic pathways in hearts of high fat diet-fed rats.
    Elrashidy RA
    Mol Biol Rep; 2020 Apr; 47(4):2821-2834. PubMed ID: 32239469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of inflammatory and fibrogenic pathways in heart failure associated with aging.
    Chen W; Frangogiannis NG
    Heart Fail Rev; 2010 Sep; 15(5):415-22. PubMed ID: 20213186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model.
    Hong SK; Choo EH; Ihm SH; Chang K; Seung KB
    Metabolism; 2017 Nov; 76():42-55. PubMed ID: 28987239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
    Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
    Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative Regulation of LRG1 by TGF-β1 and PPAR-β/δ Modulates Chronic Pressure Overload-Induced Cardiac Fibrosis.
    Liu C; Lim ST; Teo MHY; Tan MSY; Kulkarni MD; Qiu B; Li A; Lal S; Dos Remedios CG; Tan NS; Wahli W; Ferenczi MA; Song W; Hong W; Wang X
    Circ Heart Fail; 2019 Dec; 12(12):e005962. PubMed ID: 31830829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging and Cardiac Fibrosis.
    Biernacka A; Frangogiannis NG
    Aging Dis; 2011 Apr; 2(2):158-173. PubMed ID: 21837283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.